Sunnyvale, CA, United States of America

Zhehong Cai

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Zhehong Cai: Innovator in Therapeutic Antibodies

Introduction

Zhehong Cai is a prominent inventor based in Sunnyvale, California. He has made significant contributions to the field of therapeutic antibodies, particularly in cancer treatment. With a total of three patents to his name, his work is recognized for its potential impact on medical science.

Latest Patents

Cai's latest patents focus on antibodies against OX-40 and their therapeutic applications. These patents detail antibodies that bind to OX-40, which are crucial in developing treatments for cancer. The patents also include information on the cells that produce these antibodies, as well as the polynucleotides encoding the heavy and light chain variable regions of the antibodies. This innovative work opens new avenues for cancer therapy.

Career Highlights

Zhehong Cai is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research in therapeutic applications. His expertise in antibody development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Cai collaborates with talented coworkers, including Indrani Chakraborty and Marie-Michelle Navarro Garcia. Together, they contribute to the innovative research environment at Bristol-Myers Squibb.

Conclusion

Zhehong Cai's work in developing antibodies against OX-40 showcases his commitment to advancing cancer treatment. His contributions to the field of therapeutic antibodies are invaluable and highlight the importance of innovation in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…